Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Scorpius Holdings Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Scorpius Holdings Inc (SCPX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-75.08 %
Q3 2025
Net Margin
-521.91 %
Q3 2025

Key Findings: Scorpius Holdings Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 2M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-46.4% annualized vs trailing 12 months).
  • Peer revenue share: Scorpius Holdings Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

SCPX Sales vs. its Competitors, Q3 2025

Scorpius Holdings Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/SCPX/competitors
https://api.csimarket.com/api/v1/companies/SCPX/relationships
https://api.csimarket.com/api/v1/companies/SCPX/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Major Pharmaceutical Preparations industry grew revenue 9.0% year over year, combined, vs -75.1% for Scorpius Holdings Inc. Scorpius Holdings Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Scorpius Holdings Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Scorpius Holdings inc No No No Yes
Similar Growth & Profitability (8) 0.00 % (0 of 8) 37.50 % (3 of 8) 37.50 % (3 of 8) 87.50 % (7 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2025

100%market share
  • Scorpius Holdings Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Scorpius Holdings Inc and its 0 tracked competitors.

See Scorpius Holdings Inc's full market share breakdown »

SCPX Stock Performance relative to its Competitors

SCPX Competitors (weighted) Percent change over the selected range

SCPX Stock Performance relative to Similar Growth & Profitability Competitors

SCPX Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Scorpius Holdings Inc's Comment on Competition and Industry Peers

The company operates in the biopharmaceutical manufacturing market, focusing on mammalian and microbial cell culture manufacturing. It notes that consolidation in the contract development and manufacturing organization (CDMO) industry has resulted in a limited number of qualified, agile, and independent CDMOs with these capabilities.
Get the full CSIMarket dataset: Subscribe API License